Cat. No.: DIA-0230715
Product Information | |
---|---|
CAS No. | 1425043-73-7 |
Formula | C25H25N7O2 |
Molecular Weight | 455.51 |
SMILES | CC(C)N1C(=O)C2=C(C=CC=C2C=C1C(C)NC3=C(C#N)C(=NC=N3)N)C4=CN(C)C(=O)C=C4 |
Target | p110δ |
Product Description | IPI-3063 is a potent and selective p110δ inhibitor with biochemical IC50 of 2.5 ± 1.2 nM and IC50 values for the other class I PI3K isoforms (p110α, p110β, p110γ) are at least 400-fold higher. |
Format & Storage | |
---|---|
Purity | > 99% |
Shipping | Shipped on dry ice. |
Storage | Powder: -20 °C, 3 years; 4 °C, 2 years In solvent: -80 °C, 6 months; -20 °C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.